News and Events

News

All categories

Earnings

Press Release

All years

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

Affimed Reports Financial Results for Second Quarter 2018 and Operational Progress

August 8, 2018

Affimed Announces Second Quarter 2018 Financial Results and Corporate Update Conference Call

August 3, 2018

Affimed Announces Updated Data of AFM13 in Combination with Keytruda^® (Pembrolizumab) in Patients with Relapsed/Refractory Hodgkin Lymphoma Presented at EHA

June 15, 2018

Affimed to Present at the Jefferies Global Healthcare Conference

May 30, 2018

Affimed Announces Annual General Meeting of Shareholders

May 18, 2018

Affimed Reports Financial Results for First Quarter 2018

May 15, 2018

Affimed Announces First Quarter 2018 Financial Results and Corporate Update Conference Call

May 8, 2018

Affimed to Present at Deutsche Bank's 43rd Annual Health Care Conference

May 3, 2018

Affimed Introduces ROCK™ Platform for Tailored Immune Cell Engagers

May 3, 2018

Affimed Presents Poster at AACR Highlighting Progress Toward Novel EGFR-targeting Therapy

April 16, 2018

Events

All

Scientific

Investors

There are no events planned at the moment.

Webcasts More events

News and Events

News and Events

See what’s new at Affimed

See what’s new at Affimed

News

Affimed Reports Financial Results for Second Quarter 2018 and Operational Progress

Affimed Announces Second Quarter 2018 Financial Results and Corporate Update Conference Call

Affimed Announces Updated Data of AFM13 in Combination with Keytruda^® (Pembrolizumab) in Patients with Relapsed/Refractory Hodgkin Lymphoma Presented at EHA

Affimed to Present at the Jefferies Global Healthcare Conference

Affimed Announces Annual General Meeting of Shareholders

Affimed Reports Financial Results for First Quarter 2018

Affimed Announces First Quarter 2018 Financial Results and Corporate Update Conference Call

Affimed to Present at Deutsche Bank's 43rd Annual Health Care Conference

Affimed Introduces ROCK™ Platform for Tailored Immune Cell Engagers

Affimed Presents Poster at AACR Highlighting Progress Toward Novel EGFR-targeting Therapy

Events